Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64611, first published .
Leveraging Patient-Reported Outcome Measures for Optimal Dose Selection in Early Phase Cancer Trials

Leveraging Patient-Reported Outcome Measures for Optimal Dose Selection in Early Phase Cancer Trials

Leveraging Patient-Reported Outcome Measures for Optimal Dose Selection in Early Phase Cancer Trials

Journals

  1. Mitchell S, Altshuler R, St. Germain D, Streck B, Chen A, Minasian L. Measuring the multidimensional aspects of tolerability. Cancer 2025;131(S2) View